MedPath

Safety and efficacy of landiolol in controlling heart rate of supraventricular tachyarrhythmias in patients with severe sepsis

Completed
Conditions
Supraventricular tachyarrhythmias with sepsis
Circulatory System
Supraventricular tachycardia
Registration Number
ISRCTN70831305
Lead Sponsor
Kanazawa University Hospital (Japan)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
61
Inclusion Criteria

1. All patients who admitted to intensive care unit of the Kanazawa University Hospital from January 2006 to December 2011
2. Systemic inflammatory response syndrome score = 2 with infection
3. Supraventricular tachyarrhythmias with HR = 120 bpm for >1 h

Exclusion Criteria

1. Less than 18 years old
2. History of chronic supraventricular tachyarrhythmias
3. Supraventricular tachyarrhythmias at the time of ICU admission

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath